[1]
MD, R. et al. 2019. Development and In Vivo Evaluation of Mesalazine Colon Targeted Tablets. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 12, 3 (May 2019), 4552–4558. DOI:https://doi.org/10.37285/ijpsn.2019.12.3.6.